Press Releases

September 21, 2018 Cinfa Biotech receives positive CHMP opinion for Pelmeg® (pegfilgrastim), a proposed biosimilar to Neulasta®
December 14, 2017 Cinfa Biotech begins US partnering and prepares US development for B12019, a proposed biosimilar to Neulasta® (pegfilgrastim)
November 2, 2017 Cinfa Biotech presents additional clinical data for pegfilgrastim biosimilar candidate B12019 at the 59th ASH Annual Meeting
October 4, 2017 European Medicines Agency accepts Marketing Authorisation Application for Cinfa Biotech’s pegfilgrastim biosimilar B12019 for review
September 5, 2017 Cinfa Biotech reports clinical development data for pegfilgrastim biosimilar candidate B12019 at the ESMO Congress 2017
May 17, 2017 Cinfa Biotech announces positive top-line data from second clinical study with pegfilgrastim biosimilar candidate B12019
December 2, 2016 Cinfa Biotech publishes clinical data abstract at the 58th American Society of Hematology (ASH) Annual Meeting 2016
September 26, 2016 Cinfa Biotech starts second clinical study of pegfilgrastim biosimilar candidate B12019
July 4, 2016 Cinfa Biotech announces positive top-line clinical data of pegfilgrastim biosimilar candidate B12019
June 2, 2016 Cinfa Biotech to participate at four upcoming European and international conferences
April 7, 2016 Cinfa Biotech to share its experience on the development of biosimilars at three upcoming conferences
February 9, 2016 Cinfa Biotech to present at two upcoming biosimilar conferences to discuss clinical development strategies
January 14, 2016 Cinfa Biotech tritt Arbeitsgemeinschaft Pro Biosimilars bei
November 16, 2015 Cinfa Biotech treats first subjects in pegfilgrastim biosimilar clinical trial
October 8, 2015 Cinfa Biotech initiates biosimilar strategy with pegfilgrastim candidate to treat neutropenia